Niki BioSolutions regains Nasdaq minimum bid price compliance

Aptorum Group Ltd

Received Nasdaq deficiency letter on March 5, 2026 for bid price below $1.00 for 30 consecutive business days.
On August 4, 2026, Nasdaq confirmed compliance as closing bid price was $1.00+ for 10 consecutive days (July 21-Aug 3, 2026).
Listing matter now closed; company avoids delisting from Nasdaq Capital Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.